Chondrosarcoma: a clinical review
A Gazendam, S Popovic, N Parasu… - Journal of Clinical …, 2023 - mdpi.com
Chondrosarcomas are a diverse group of malignant cartilaginous matrix-producing
neoplasms. Conventional chondrosarcomas are a continuum of disease based on the …
neoplasms. Conventional chondrosarcomas are a continuum of disease based on the …
TP53 in bone and soft tissue sarcomas
E Thoenen, A Curl, T Iwakuma - Pharmacology & therapeutics, 2019 - Elsevier
Genomic and functional study of existing and emerging sarcoma targets, such as fusion
proteins, chromosomal aberrations, reduced tumor suppressor activity, and oncogenic …
proteins, chromosomal aberrations, reduced tumor suppressor activity, and oncogenic …
Chondrosarcoma-from molecular pathology to novel therapies
AE Zając, S Kopeć, B Szostakowski, MJ Spałek… - Cancers, 2021 - mdpi.com
Simple Summary Chondrosarcoma (CHS) belongs to a broad group of sarcomas and is the
second most frequent malignant bone tumor. Due to its resistance to chemo-and …
second most frequent malignant bone tumor. Due to its resistance to chemo-and …
Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets
E Nazeri, MG Savadkoohi, K Majidzadeh-A… - Critical reviews in …, 2018 - Elsevier
Sarcomas are known as a heterogeneous class of cancers arisen in the connective tissues
and demonstrated various histological subtypes including both soft tissue and bone origin …
and demonstrated various histological subtypes including both soft tissue and bone origin …
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma
W Chow, P Frankel, C Ruel, DM Araujo, M Milhem… - Cancer, 2020 - Wiley Online Library
Background This single‐arm, multicenter, phase 2 study evaluated the safety and antitumor
activity of pazopanib in patients with unresectable or metastatic conventional …
activity of pazopanib in patients with unresectable or metastatic conventional …
Osteosarcoma, chondrosarcoma and Ewing sarcoma: Clinical aspects, biomarker discovery and liquid biopsy
V Aran, S Devalle, W Meohas, M Heringer… - Critical Reviews in …, 2021 - Elsevier
Bone sarcomas, although rare, are associated with significant morbidity and mortality. The
most frequent primary bone cancers include osteosarcoma, chondrosarcoma and Ewing …
most frequent primary bone cancers include osteosarcoma, chondrosarcoma and Ewing …
Emerging targeted and immune-based therapies in sarcoma
SM Pollack, M Ingham, MB Spraker… - Journal of Clinical …, 2018 - ascopubs.org
Soft tissue and bone sarcomas are malignancies of mesenchymal origin, and more than 50
subtypes are defined. For most sarcomas, locally advanced or unresectable disease is still …
subtypes are defined. For most sarcomas, locally advanced or unresectable disease is still …
Chondrosarcoma: a rare misfortune in aging human cartilage? The role of stem and progenitor cells in proliferation, malignant degeneration and therapeutic …
Unlike other malignant bone tumors including osteosarcomas and Ewing sarcomas with a
peak incidence in adolescents and young adults, conventional and dedifferentiated …
peak incidence in adolescents and young adults, conventional and dedifferentiated …
Bone sarcomas in the immunotherapy era
MF Heymann, K Schiavone… - British Journal of …, 2021 - Wiley Online Library
Bone sarcomas are primary bone tumours found mainly in children and adolescents, as
osteosarcoma and Ewing's sarcoma, and in adults in their 40s as chondrosarcoma. The last …
osteosarcoma and Ewing's sarcoma, and in adults in their 40s as chondrosarcoma. The last …
The osteoclast traces the route to bone tumors and metastases
S Russo, F Scotto di Carlo… - Frontiers in Cell and …, 2022 - frontiersin.org
Osteoclasts are highly specialized cells of the bone, with a unique apparatus responsible for
resorption in the process of bone remodeling. They are derived from differentiation and …
resorption in the process of bone remodeling. They are derived from differentiation and …